Overview

Study To Investigate The Hemodynamic Effects Of Single Dose Vardenafil In Subjects Receiving Maraviroc

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to estimate the effects of a single dose of vardenafil on the blood pressure (BP) in subjects receiving maraviroc (MVC) (dosed to steady-state) and to assess the safety and tolerability of MVC in subjects receiving a single dose of vardenafil.
Phase:
Phase 4
Details
Lead Sponsor:
ViiV Healthcare
Collaborator:
Pfizer
Treatments:
Maraviroc
Vardenafil Dihydrochloride